- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
VESOMNI - - 30
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G04CA53 | B | Tamsulosin HCl - 0.4mg, Solifenacin succinate - 6mg | 9318 | 108217/1 | VESOMNI | 30 | Tablet, modified release | Oral | Mersaco | Astellas Pharma Europe BV | The Netherlands | 4,491,174 L.L | 23.08 | B | Astellas Pharma Europe BV | The Netherlands | 2/5/2024 | 0 |